Bk of NY Mellon saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96.
Looking For The Best Stocks To Buy And Watch? Start Here
The upgrade means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.
Bk of NY Mellon is currently extended beyond a proper buy zone after clearing the 90.34 entry in a consolidation.
The stock earns a 93 EPS Rating, which means its recent quarterly and annual earnings growth tops 93% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
In Q2, the company posted 28% earnings-per-share growth. Revenue growth rose 9%, up from 6% in the prior quarter. That marks one quarter of accelerating revenue increases.
Bk of NY Mellon earns the No. 3 rank among its peers in the Banks-Money Centers industry group. Barclays ADR is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
